SC 13G Filing

Company

Protalix BioTherapeutics, Inc.

Filed

April 20, 2015

Accession Number

0001546927-15-000122

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →